Posted On: 10/09/2014 10:17:11 AM
Post# of 30066
LymPro revenue generation is everything right now! It will start in January. That is why I think we'll up list around February 1.
The company I was in before, which made me great money, was nothing compared to AMBS. It had a new drug that started selling. Wall Street loves new revenue generators. The pps in that stock shot up big time as the revenue started coming in.
So that's why I am so excited about what LymPro is going to do for us in 2015!!!
But when it comes time to up list, if we are only at .25 cents and we do a 1:16 RS to up list at $4 on NASDAQ, that doesn't frighten me at all. I do not consider that a massive RS. With revenue coming in and MANF indications getting orphan designation, we will not get hurt with at 1:16 RS.
The company I was in before, which made me great money, was nothing compared to AMBS. It had a new drug that started selling. Wall Street loves new revenue generators. The pps in that stock shot up big time as the revenue started coming in.
So that's why I am so excited about what LymPro is going to do for us in 2015!!!
But when it comes time to up list, if we are only at .25 cents and we do a 1:16 RS to up list at $4 on NASDAQ, that doesn't frighten me at all. I do not consider that a massive RS. With revenue coming in and MANF indications getting orphan designation, we will not get hurt with at 1:16 RS.
(0)
(0)
